REGULATORY ACTIONS UNDER REACH & CLP FEEDBACK FROM ECHA S RAC

Similar documents
REACH restriction process. REACH Conference Bratislava September 3-4, 2018

REACH: how to deal with 30,000 chemicals

REACH&CLP: CURRENT STATUS AND NEXT STEPS OF THE DIFFERENT PROCEDURES

Risk Management Option Analysis Conclusion Document

REACH Authorisation. Elanor Ball UK REACH Competent Authority

Endocrine discuptors under REACH

REACH Review: Industry activities and views

SVHC Authorisation and Restrictions

Authorisation in REACH

How to address chemicals of concern: roadmap 2020

Current and future EU policy on Substance Restrictions. Halogen-free Symposium Brussels October 27-28, 2009

Substance Evaluation Conclusion document: Beryllium EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.

Introduction to Common Screening

Implementation of REACH and CLP: Overview, Status and post 2018 possible actions

Feedback from ECHA on dossier and substance evaluation

Justification Document for the Selection of a CoRAP Substance - Update -

Authorisation applications : process, learning lessons and suggestions. Aggie Kötze (REACH Manager, ILA))

Eu regulatory framework for promoting substitution. REACH Authorisation. Dolores Romano Substitution Expert for the European Environmental Bureau

REACH REGULATION: the new management of chemicals in Europe and operational tools. R egistration. E valuation. A Ch. uthorisation.

Risk Management Option Analysis Conclusion Document

Overview in analysing the costs and benefits of applications of authorisation and restrictions under REACH

REGULATIONS. L 44/2 Official Journal of the European Union

Background document for 4,4 -Diaminodiphenylmethane (MDA)

EU legislation: Chemicals REACH

REGULATIONS. L 44/2 Official Journal of the European Union

Implementing REACH - Safer chemicals in Europe

Position Paper. Ensuring a truly complementary, coherent and consistent implementation of REACH and RoHS2 EXECUTIVE SUMMARY

27 February 9 March ECHA Conference Centre (Annankatu 18, Helsinki) Tuesday 27 February starts at Friday 9 March ends at 13.

Behind the scenes of screening for SVHCs. Subtitle

REACH overview why, what s the objective?

Biocidal Products Committee (BPC)

Risk Management Option Analysis Conclusion Document

REACH Roadmap for Petroleum Substances update

Update from ECHA. REACH Information and Experience Exchange Forum (RIEF IV) CEFIC 19 June 2015 Sheraton Brussels Airport Hotel

Council of the European Union Brussels, 16 January 2017 (OR. en)

PLANNING FOR REACH 2018 AS A NON-EU COMPANY

ECHA s Annual Stakeholder Survey 2016

Biocidal Products Committee (BPC)

Review of the scope of REACH and other relevant EU legislation according to Article 138(6) REACH: description of gaps and overlaps

(Text with EEA relevance)

Endocrine Disruptors within the context of REACH

Background document for diarsenic pentaoxide

Formaldehyde and formaldehyde releasers - Strategy for future work

Justification Document for the Selection of a CoRAP Substance

Risk management get ready

REACH Authorisation and Use of Cr(VI) in the EEA

29 February - 10 March ECHA Conference Centre (Annankatu 18, Helsinki)

ECHA 1(7) Helsinki, 19 May 2014

COMMISSION DIRECTIVE 2011/71/EU

COMMISSION OF THE EUROPEAN COMMUNITIES COMMUNICATION FROM THE COMMISSION

Second REACH review and next steps

RISK & POLICY ANALYSTS LTD. Highly regarded for our superior services by clients, contemporaries and colleagues alike

General Approach for Prioritisation of Substances of Very High Concern (SVHCs) for Inclusion in the List of Substances Subject to Authorisation

ECHA s Annual Stakeholder Survey Overview of results

Biocidal Products Committee (BPC)

Interface between REACH and CAD:

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 22 JUNE 2016

Experiences of Enforcement with authorisation

Recommendation about n-methyl-pyrrolidone (NMP; CAS no ) proposal for inclusion in Annex XIV for authorization.

REACH and OSH: ensuring effective worker protection from chemical risks

Work Programme Working for the safe use of chemicals across the EU

Background document for sodium dichromate

Substitution of hazardous chemicals: training on decision support tools to assess hazard and sustainability of chemicals and alternatives

The new Biocidal Products Regulation. Outline and key elements

Benefit-Cost Analysis in Chemicals Regulation in the EU

General Information. Theme 1 - Information on the Competent Authority. More than one Competent Authority Responsible for REACH

CHEMAWARE Knowledge Services FAQ: Trichloroethylene under REACH

Annex to a news release

COMMISSION DELEGATED DIRECTIVE../ /EU. of

Public Consultation in relation to the REACH REFIT evaluation

REACH. Intertek Group PLC July By Ms. Sunanda Kadam. Intertek REACH Presentation, May

Introduction to GHS. The Globally Harmonised System of Classification and Labelling of Chemicals. Cecilia Westöö April 2014 Bangkok

The keystones of the proposed approach, presented in section 4 of that document, were the followings:

Workshop Assessment of Persistent, Bioaccumulative and Toxic (PBT) substances in different EU legislations

Werknorm BN e Material Compliance Blatt 1 von 7

ANALYSIS OF THE MOST APPROPRIATE RISK MANAGEMENT OPTION (RMOA) Substance name: Methanol EC number: CAS number:

Contents Page 1. Introduction Context of this Document How to use this Guidance Overview of REACH

ECHA Programming Document

COMMISSION IMPLEMENTING DECISION. of

Biocidal Products Committee (BPC)

FINAL DRAFT REACH: STATUS, CHALLENGES AND CURRENT WORK. ETRMA CRIA meeting Tyre Industry Regulatory Dialogue

COMMISSION IMPLEMENTING DECISION. of

Substance name: Diarsenic Pentaoxide EC number: CAS number: PRIORITISATION AND ANNEX XIV BACKGROUND INFORMATION

THE CHEMICALS (HEALTH AND SAFETY) AND GENETICALLY MODIFIED ORGANISMS (AMENDMENT OF RETAINED EU LAW) (EU EXIT) REGULATIONS 2018

Biocidal Products Committee (BPC)

ECHA policy for prevention of conflicts of interest

REACh Made Simple. Simple Guide to REACh Regulations. Hints, Tips and Actions. What is the aim of REACh? Who does REACh apply to? Your REACh role!

EN 1 EN 1. INTRODUCTION

REACH and the Challenge to the Leather Industry

What does it mean for US Businesses, Sustainable Chemistry and Product Design?

Biocidal Products Committee (BPC)

Biocidal Products Committee (BPC)

REACH: What ITI members need to know to limit business risk

Q and A on the new Chemicals policy, REACH

Update on cables under RoHS

Chemical safety report (CSR) and exposure scenarios

AT Experiences with the Zonal Evaluation Process (2)

REACHing the 2020 goals

Guidance on applications for technical equivalence

Intertek Regulatory Services

Transcription:

REGULATORY ACTIONS UNDER REACH & CLP FEEDBACK FROM ECHA S RAC Luxembourg, 8 December 2016 Annual Conference REACH&CLP Ruth MOELLER

CONTENT ECHA and its Committees How substances of concern are regulated Tasks of the RAC Harmonised classification and labelling - CLP Application for Authorisation - REACH Restriction - REACH Art 95(3) REACH: Conflicts of opinions with other bodies

ECHA AND ITS COMMITTEES European Chemicals Agency: regulatory authority for implementing the EU's chemicals legislation. Member States Committee (MCS) Risk Assessment Committee (RAC) Committee for Socio-Economic Assessment (SEAC) Biocidal Products Committee (BPC) Forum REACH CLP Regulation (EC) No 1907/2006 on the Registration, Evaluation, Authorisation and Restriction of Chemicals BPR Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products Regulation (EC) No 1272/2008 on the classification, labelling and packaging of substances and mixtures PIC Regulation (EU) 649/2012 concerning the export and import of hazardous chemicals

Screening IUCLID Database External sources REACH Evaluation Registration Dossier Compliance Check Substance Evaluation - CoRAP MSC Further Info & assessment Concern? No No Action C&L Inventory Informal hazard assessment Yes Risk Management Option Analysis (RMOA) RoI REACH & CLP No Action Other legislation Harmonised C&L Annex VI CLP RAC Restriction Annex XVII REACH SEAC Forum MSC Candidate List SVHC Annex XIV REACH OSH - OEL WFD Priority list POP Regulation RoI = Registry of Intentions, CoRAP = Community Rolling Action Plan, SVHC = Substance of Very High Concern, C&L = Classification & Labelling, OSH = Occupational Health & Safety, OEL = Occupational Exposure Level, WFD = Water Framework Directive, POP = Persistent Organic Pollutants Application for Authorisation RAC SEAC

CLP - HARMONISED CLASSIFICATION Regulation (EC) 1272/2008 Classification, Labelling and Packaging (CLP) Harmonisation of classification and labelling at an EU level (legally binding) Focus on substances which are of most concern to humans Carcinogenic (C) Mutagenic (M) Reproductive toxicants (R) Respiratory sensitisers (RS) Other hazard classes can be harmonised on a case-by-case basis justification needed Active substances in plant protection products (PPP) and biocidal products (BP) shall normally be subject to harmonised classification and labelling all hazard classes. Harmonised classified substances are included in Annex VI CLP

HARMONISED CLASSIFICATION - PROCESS OVERVIEW Main actors: Dossier submitter (Member states Competent Authority or industry) ECHA / Committee for Risk Assessment Parties Concerned including other MSCAs, individuals and NGOs European Commission RoI CLH Dossier preparation Public Consultation (45 days) RAC opinion adoption and publication Commission Review and Draft decision 18 months to adopt an opinion (legally binding) RAC and its Rapporteurs: Examine the CLH proposals and prepare an opinion on the proposed harmonised classification for a substance 6 RoI = Registry of Intentions, CLH = Harmonised Classification & Labelling

CLP - HARMONISED CLASSIFICATION RAC Opinion development RAC opinion Commission Commission (DG Enterprise & Environment) Decision on inclusion in Annex VI of CLP, based on opinion adopted by RAC Commission acts as observer at RAC meetings Manufacturer / Importer / DU: Following the inclusion of the substance in Annex VI to the CLP, all manufacturers, importers and downstream users of the substance in the EU must classify the substance in accordance with the entry in Annex VI. Hazard classes not included in the Annex VI entry must be self-classified and labelled accordingly.

CLP - HARMONISED CLASSIFICATION Some statistics (status Sep 2016) 2014 400 350 336 372 300 250 200 150 100 50 0 CLH dossiers processed 47 14 12 0 1 179 123 77 42 49 17 280 268 236 233 227 207 193 203 165 147 107 114 80 2008 2009 2010 2011 2012 2013 2014 2015 2016 Submitted proposals Public consultations completed RAC opinions finalised

CLP - HARMONISED CLASSIFICATION Registry of Intentions

REACH - AUTHORISATION RAC opinion development To ensure that the risks from Substances of Very High Concern (SVHC) are properly controlled and that these substances are progressively replaced by suitable alternatives while ensuring the good functioning of the EU internal market. Substances on the Authorisation List (Annex XIV of REACH) cannot be used or placed on the market for a use after a specific sunset date Unless an application for authorisation (AfA) is granted Unless an application has been submitted before the latest application date (and a decision has not yet been made). Substances of very high concern (SVHC) Annex XIV recommnendation Candidate List Annex XIV entry Authorisation List AfA Opinion of RAC/SEAC including recommendation for review period

APPLICATION FOR AUTHORISATION - PROCESS OVERVIEW RAC: assessment of risk to human health and / or environment from the use applied for, including appropriateness and effectiveness of Risk Management Measures and, if relevant, risk from possible alternatives.

REACH - AUTHORISATION Some statistics Received notifications to submit Received 1 applications (applicants) Number of uses RAC-SEAC opinions per use RAC-SEAC opinions per use and per applicant 2012 5 0 (0) 0 0 0 0 2013 11 8 (10) 17 1 1 0 2014 170 19 (33) 38 30 34 2 2015 72 7 (20) 13 25 51 10 2016* 14 77 (132) 112 33 74 47 Total 272 111 (195) 180 89 160 59 Commission decisions per use and per applicant *Indicative status on 17 November 2016, subject to rapid change; 1 Fee paid Joint RAC-SEAC Opinions per Use

REACH - AUTHORISATION Some statistics Substance Number of received* AfAs (Applicants) Indicative status on 17 November 2016, subject to rapid change; *Fee paid Number of uses RAC-SEAC opinions per use RAC-SEAC opinions per use and applicant Commission decision (per use and applicant) Phthalates 8 (10) 17 17 21 14 Lead chromate pigments 1 (1) 12 12 12 12 HBCDD 1 (13) 2 2 26 26 Diarsenic trioxide 4 (4) 5 5 5 5 Trichloroethylene 13 (15) 19 19 21 2 Lead chromate 1 (1) 1 1 1 EDC 10 (12) 12 1 1 Chromium VI substances 57 (123) 110 47 88 Diglyme 8 (8) 9 1 1 Arsenic acid 1 (1) 1 Technical MDA 1 (1) 2 MOCA 1(1) 1 Total: 111 (195) 180 89 160 59

REACH - AUTHORISATION Some statistics Companies Single applicant One or more own uses on own site(s) Consortium: single or multiple own uses on multiple (named) sites Single applicant or consortium: single or multiple uses on multiple (mostly un-named) sites covering part of a supply chain OC = Operational Conditions, RMM = Risk Management Measures Uses and sites Typical, compact downstream applications from SME s to large multi-nationals Larger, more complex downstream applications representativeness of OC, RMM and exposure data comes into play Very large upstream applications, where representative standards on OC, RMM and exposure data are proposed OC = Operational Conditions, RMM = Risk Management Measures

REACH - AUTHORISATION Some statistics RAC and SEAC have recommended a variety of review periods both with and without conditions for the authorisation and/or the review report RAC: Exposure monitoring, review / introduce / strengthen Risk Management Measures, maintain records for inspection by enforcement authorities. SEAC: quantities used, timeline, scope of alternative assessment

REACH - AUTHORISATION Positive effects for the protection of workers No applications, or only very few were received for some Annex XIV substances. About 25% of applications request shorter review periods as a bridge to alternative substances. Authorisation has stimulated fresh workplace exposure investigations Nearly all downstream applications indicate new (2013-2015) campaigns to measure exposure or, to show the intensification of existing monitoring programmes Many applications already show improvements to operational conditions and risk management measures as a result of monitoring and reassessment in the preparing the application Improvement in specific RMMs during the preparation of the application Implementation of plans to reduce overall exposure to SVHC SVHC = Substances of Very High Concern RMM = Risk Management Measures

REACH - RESTRICTION Continues the work done under Directive 76/769/EEC A safety net: Restrictions limit or ban the manufacture, placing on the market or use of certain substances that pose an unacceptable risk to human health and the environment Authorisation or other Community actions are not more appropriate Other REACH processes do not ensure adequate control of risks Community-wide action: the same requirements apply to whole EU from entry into force Restrictions may be imposed on: Manufacture, use and/or placing on the market A substance on its own, in preparation or in an article, when

REACH - RESTRICTION Preparatory work Notify Prepare Annex XV Restriction Dossier 12 months Submit Registry of Intentions Comments 6 months Comments 60 days RAC and its Rapporteurs: Examine the restriction proposals and prepare an opinion whether the suggested restriction is appropriate in reducing the risks to human health and/or the environment (Art. 70) Check conformity echa.europa.eu SEAC opinion 12 months RAC opinion 9 months Finalise Commission: Draft amendment 3 months Amend Annex XVII

REACH - RESTRICTION Specific restriction cases: Carcinogenic, mutagenic and toxic to reproduction (CMR category 1A/1B): Used by consumers (substance as such, in mixture or in articles): Entry 28-30 REACH Annex XVII Annex XIV substances (authorisation list) A69(2): After sunset date, ECHA considers if the use of the substance in articles causes risk that is not adequately controlled and prepares a restriction proposal Article 129 cases Safeguard clause MSs take appropriate provisional measures if urgent actions are needed, e.g. ammonium salts in cellulose Commission decision - if authorising provisional measures: Annex XV dossier submission to ECHA by the Member State

REACH - RESTRICTION Ongoing opinion making and proposal preparation PL: Methanol in windshield washing fluids (finished Dec 2015) UK: D4/D5 in personal care products (finished June 2016) DK: TDFA in spray products (conformity) ECHA/DK: Phthalates - DEHP, DBP, DIBP, and BBP in articles (conformity) IT: DMF (submission in 7/2016) DE: Isocyanates (submission in 10/2016) ECHA: Lead stabilisers in PVC (submission in late 2016) ECHA: Lead shot in wetlands (submission in mid 2017) ECHA: CMRs/sensitisers in Tattoo inks and permeant make up (submission in late 2017)

REACH - RESTRICTION Ongoing proposals Brief title: The restriction is a ban on the use of TDFA s in mixtures containing organic solvents placed on the market or used in spray products for consumers (aerosol dispensers, pump and trigger sprays and mixtures marketed for spray application)

REACH - RESTRICTION Ongoing proposals Brief title: Restriction on articles containing the four phthalates for: i) indoor use ii) outdoor use, if in contact with human skin or mucous membranes

REACH - RESTRICTION Registry of Intentions

ART 95(3) REACH: CONFLICTS OF OPINIONS WITH OTHER BODIES Art. 95(3): Where there is fundamental conflict over scientific or technical points and the body concerned is a community agency or a scientific committee, the Agency and the body concerned shall work together either to solve the conflict or to submit a joint document to the Commission clarifying the scientific and /or technical points of conflict. ECHA and SCOEL are therefore requested to establish a joint Task Force for the comparative critical assessment of REACH DNEL and OEL methodologies a) for the inhalation route and b) for dermal route, including skin notation and dermal DNEL

Thank you for your attention! Thanks to for support